Innovative skin patch may offer long-term contraception
Researchers have used microneedle skin patch technology and biodegradable polymers to devise a long-lasting contraception method. …read more
Younger Women Misinterpret Risks of HRT, Forgo Benefits
A new analysis documents the hows and whys of the dramatic reductions in HRT use following the halting of the Women’s Health Initiative trial. Risks and benefits of HRT continue to be misinterpreted. Medscape Medical News …read more
The Many Forms of HPV: Recognition and Management
Through a series of short cases, Dr Gordon Sun addresses the recognition and early assessment of patients with suspected HPV-related disease and cancers. Medscape Family Medicine …read more
Hormone Therapy May Protect Against Knee Osteoarthritis
Postmenopausal women taking hormone therapy were significantly less likely to develop symptomatic knee osteoarthritis compared with those who did not take hormone therapy, a large study has found. Medscape Medical News …read more
What to know about the Adam’s apple
The Adam’s apple is a lump of cartilage in the throat, and it develops in males and females. It has no specific use and can be surgically removed. Learn more here. …read more
Oral HRT for Menopause Has Highest VTE Risk, Dermal Route Safest
Women taking HRT for menopausal symptoms should be counseled to use transdermal preparations over oral ones to reduce their venous thromboembolism risk, conclude UK experts following large study. Medscape Medical News …read more
¿Qué significan los diferentes tipos de secreción vaginal?
Aprenda qué es lo que significan los diferentes tipos de secreción vaginal para la salud de una persona, así como las posibles causas de una secreción vaginal no saludable. …read more
Remedios caseros para la vaginosis bacteriana
La vaginosis bacteriana es la infección vaginal más común. ¿Qué la causa, funcionan los remedios caseros? En este artículo responderemos estas preguntas y más. …read more
Osteoporosis Drug Romosozumab Gains First Approval, in Japan
First approval worldwide for anabolic agent romosozumab for osteoporosis in women at high risk of fracture. The FDA previously rejected it, but an advisory committee will discuss the agent in 2 weeks. Medscape Medical News …read more
US Cervical Cancer Screening Rates ‘Unacceptably Low’
Clinicians need to think ‘outside the box’ to make sure more women receive guideline-recommended screening. Medscape Medical News …read more